SP

Sandip Prakashrao Kukse

Active Director Director DIN 07866842
DIN 07866842 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Sandip Prakashrao Kukse

Data last updated:

Sandip Prakashrao Kukse is a Director at Vizyon Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Vizyon Pharmaceuticals Private Limited reported revenue of ₹2.87 Cr (FY 2025).

DIN 07866842
Primary Designation Director
Industry Pharma
First Appointment 03 Jul 2017
Oldest Company Age 9 yrs
Largest company Vizyon Pharmaceuticals Private Limited · ₹2.87 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20172017₹2.87 Cr (FY 2025)Active

Board colleagues of Sandip Prakashrao Kukse

NameDINCompanyDesignation
Neelima Kukse07866875Vizyon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vizyon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sandip Prakashrao Kukse

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Prakashrao Kukse

Sandip Prakashrao Kukse currently holds 1 directorship: Vizyon Pharmaceuticals Private Limited (Director, since 03 Jul 2017, revenue ₹2.87 Cr (FY 2025)).

Sandip Prakashrao Kukse was first appointed on 03 Jul 2017 as Director at Vizyon Pharmaceuticals Private Limited.

The current boards of Sandip Prakashrao Kukse's companies include Neelima Kukse (Vizyon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available